LS Snapshot Cover

Life Sciences References Valuation Snapshot

10 Jun 2020

European healthcare indices and the COVID-19 impact

The COVID-19 pandemic has dramatically impacted many aspects of life. The extent of the effects still needs to be fully understood. But some impacts to the Life Sciences M&A market are already visible. Across all industries many transactions have been put on hold, as parties are concentrating on the continuity of their businesses. While some of those deals will be closed later this year, many will be stalled. The shortage of debt financing, the investment controlling regulation by the German government and purchase price disputes might reduce the number of transactions even more. In this worldwide downturn of the economy, Life Sciences companies will not be immune, but they show more resilience than other sectors.

The trend of Life Sciences companies focusing on their core businesses is now more visible than ever, as we see increased spin-offs and divestitures. We also expect increasing institutional investments in the Life Sciences sector. With less targets on the market, those opportunities will become more competitive.

As the pandemic is forcing us to go online, the trend towards digitalisation will see an immense acceleration. Changes that for long have seemed impossible due to strict regulations and cultural aversions, are now happening, including telehealth and sick leave notes via phone. Patients and providers have learned to manage the distance and use digital tools. The enormous costs burdening the providers as a consequence of the shutdowns will further drive digitalisation to dramatically increase productivity.

COVID -19 will eventually lead to a re-thinking of supply chains. China holds a central role as manufacturer, producing 90% of active pharmaceutical ingredients, thus leading to fear of shortages and dependencies. Some countries have limited their export of medical products. Businesses in the future will be required to have detailed planning on how to overcome short term supply issues. This aspect will also have a strong impact on the pricing in M&A transactions.

Most Medtech and pharma companies remained stable throughout the pandemic, while healthcare provider businesses are having difficulties. With many specialty doctor’s offices being closed, and hospitals concentrating on COVID-19 patients and emergencies rather than performing revenue-driving surgeries, the healthcare provider segment sees decreasing revenues and increasing losses. The full extent of the SARS CoV-2 virus on the Life Sciences industry will have to be evaluated at the end of the pandemic, but with the exception of provider businesses M&A activities will remain on high levels at comparably high prices.

Download the full snapshot

Team

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telefon: +49 30 809 33 47-13

LinkedIn

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telefon: +49 40 300 836-11

LinkedInXING

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telefon: +49 89 255 49 53-11

LinkedIn

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telefon: +49 40 300 836-19

LinkedIn

@

Picture of Daniel Dies
Daniel Dies

Partner

Telefon: +49 40 300 836-16

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telefon: +49 89 255 49 53-15

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telefon: +49 89 255 49 53-17

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telefon: +46 70 496 18 15

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Director

Telefon: +46 73 850 35 59

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telefon: +44 20 80176020

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telefon: +45 4199 8252

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telefon: +45 4199 8251

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telefon: +45 2634 9031

LinkedIn

@

Picture of Kurfürstendamm 188
Kurfürstendamm 188

10707 Berlin

Telefon: +49 30 809 334 70

LinkedIn

@

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telefon: +49 30 809 33 47-13

LinkedIn

@

Picture of Eva Macha
Eva Macha

Office Management

Telefon: +49 30 809 33 47-10

LinkedIn

@

Picture of Jessica Algner
Jessica Algner

Office Management

Telefon: +49 30 809 33 47-12

LinkedIn

@

Picture of Nils Zettelmeyer
Nils Zettelmeyer

Director

Telefon: +49 30 809 33 47-25

LinkedIn

@

Picture of Thorsten Grandt
Thorsten Grandt

Vice President

Telefon: +49 30 809 33 47-20

LinkedIn

@

Picture of Toldbodgade 57
Toldbodgade 57

1253 Copenhagen K

Telefon: +45 3945 0010

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telefon: +45 4199 8252

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telefon: +45 4199 8251

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telefon: +45 2634 9031

LinkedIn

@

Picture of Esplanade 41
Esplanade 41

20354 Hamburg

Telefon: +49 40 300 83 60

LinkedIn

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telefon: +49 40 300 836-11

LinkedInXING

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telefon: +49 40 300 836-19

LinkedIn

@

Picture of Daniel Dies
Daniel Dies

Partner

Telefon: +49 40 300 836-16

LinkedIn

@

Picture of Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Buchhaltung

Telefon: +49 40 300 836 10

LinkedIn

@

Picture of Elaine Kelly
Elaine Kelly

PR, Marketing & Business Development Manager

Telefon: +49 40 300 836 18

LinkedIn

@

Picture of Mischa Krause
Mischa Krause

Director

Telefon: +49 40 300 836-24

LinkedIn

@

Picture of 14 Buckingham Street
14 Buckingham Street

London WC2N 6DF

Telefon: +44 20 8017 6020

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telefon: +44 20 80176020

LinkedIn

@

Picture of Jon Tingling
Jon Tingling

Associate

Telefon: +44 77 1347-8286

LinkedIn

@

Picture of Von-der-Tann-Straße 7
Von-der-Tann-Straße 7

80539 München

Telefon: +49 89 255 495 30

LinkedIn

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telefon: +49 89 255 49 53-11

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telefon: +49 89 255 49 53-15

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telefon: +49 89 255 49 53-17

@

Picture of Anika Schaefer
Anika Schaefer

Office Management & HR

Telefon: +49 89 255 495 310

@

Picture of Birger Jarlsgatan 13
Birger Jarlsgatan 13

111 45 Stockholm

Telefon: +46 8 684 439 00

LinkedIn

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telefon: +46 70 496 18 15

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Director

Telefon: +46 73 850 35 59

LinkedIn

@

Picture of Caroline Berglund
Caroline Berglund

Strategic Business Manager

Telefon: +46 73 382 10 82

LinkedIn

@

Picture of Johan Heigard
Johan Heigard

Vice President

Telefon: +46 70 246 99 88

LinkedIn

@

Picture of Erik Foberg
Erik Foberg

Director ECM

Telefon: +46 70 434 85 03

LinkedIn

@

Picture of Markus Augustsson
Markus Augustsson

Head of Equity Research

Telefon: +46 76 235 03 20

LinkedIn

@

Picture of Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telefon: +46 70 434 90 03

LinkedIn

@

Picture of Richard Ramanius
Richard Ramanius

Associate Equity Analyst

Telefon: +46 73 539 66 99

LinkedIn

@

Picture of Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Picture of Ulf Boberg
Ulf Boberg

Senior Advisor Life Science

Telefon: +46 73 312 44 90

LinkedIn

@